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Abstract
Purpose
To characterize the histological appearance and expression of pro-inflammatory mediators,
growth factors, matrix metalloproteinases and biomarkers of epithelial-mesenchymal transi-
tion (EMT) in healthy control and trachomatous trichiasis (TT) conjunctival tissue.
Methods
Conjunctival biopsies were taken from 20 individuals with TT and from 16 individuals with
healthy conjunctiva, which served as controls. Study participants were of varying ethnicity
and were living in a trachoma-endemic region of northern Tanzania. Formalin-fixed paraf-
fin-embedded tissue sections were stained using hematoxylin and eosin or by immunohis-
tochemistry using antibodies against: IL-1β, IL-6, IL-17A, IL-22, CXCL5, S100A7, cleaved
caspase 1 (CC1), PDGF, CTGF, TGFβ2, MMP7, MMP9, E-cadherin, vimentin, and
αSMA.
Results
Tissue from TT cases had a greater inflammatory cell infiltrate relative to controls and
greater disruption of collagen structure. CTGF and S100A7 were more highly expressed
in the epithelium and IL-1β was more highly expressed in the substantia propria of TT
cases relative to controls. Latent TGFβ2 was slightly more abundant in the substantia
propria of control tissue. No differences were detected between TT cases and controls in
the degree of epithelial atrophy, the number of myofibroblasts or expression of EMT
biomarkers.
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Conclusions
These data indicate that the innate immune system is active in the immunopathology of tra-
choma, even in the absence of clinical inflammation. CTGF might provide a direct link
between inflammation and fibrosis and could be a suitable target for therapeutic treatment
to halt the progression of trachomatous scarring.
Author Summary
Progressive scarring of the conjunctiva in individuals with trachoma causes the eyelids to
contract, drawing the eyelashes inwards (trichiasis) so that they scratch the cornea, causing
pain and eventually blindness. Disease is initiated in childhood by repeated conjunctival
infection with Chlamydia trachomatis (Ct), however, infection is not commonly found in
adults, yet chronic inflammation and fibrosis progress throughout the lives of many indi-
viduals. A better understanding of the mechanisms driving inflammation and fibrosis are
required in order to develop treatments to halt disease progression. The tissue expression
and localization of a number of pro-inflammatory cytokines, growth and matrix factors
were investigated in eyelid tissue from 20 individuals with trichiasis and from 16 control
individuals. By staining tissue sections with dyes and specific antibodies, pro-inflamma-
tory signaling molecules IL-1β and S100A7 and pro-fibrotic growth factor CTGF were
found to be more highly expressed in individuals with trichiasis. CTGF and S100A7 were
highly expressed in the epithelium; the outermost layer of the conjunctiva, whereas IL-1β
was more highly expressed deeper in the tissue, where scarring occurs. Numerous inflam-
matory cells were found in the tissue of trichiasis patients even in the absence of clinically
apparent inflammation. Future research should seek to describe a causative mechanism
linking these factors.
Introduction
Trachoma is a blinding disease initiated by infection of the conjunctival epithelium with the
intracellular bacterium Chlamydia trachomatis (Ct). Individuals living in trachoma-endemic
communities are repeatedly infected with Ct, which causes a follicular conjunctivitis. Chronic,
recurrent inflammation, even in the absence of detectable Ct infection, is associated with pro-
gressive scarring [1]. The fibrotic response results in the inward turning of the lid margin
(entropion) and abrasion of the cornea by the eyelashes (trichiasis). Mechanical damage to the
cornea and subsequent opportunistic infections eventually lead to corneal opacity and
blindness.
Trachoma is endemic in 51 countries and impairs the eyesight of 2.2 million people world-
wide, 1.2 million of whom are irreversibly blind [2]. Although trachoma control programs
have made good progress in reducing active disease, there is now some evidence that estab-
lished scarring disease continues to progress even when chlamydial infection appears well con-
trolled [1]. Therefore, a large number of people remain at risk of developing incident trichiasis,
especially in areas where mass drug administration has had a partial effect [3,4]. In order to
develop a vaccine or therapeutic treatments to prevent the progression to trichiasis, a better
understanding of the immunopathology of scarring trachoma is required.
A number of clinical studies have shown that transcriptional signatures in trachomatous
scarring (TS) and trichiasis (TT) are consistent with a pro-inflammatory epithelial response
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and tissue remodeling, supporting the cellular paradigm of chlamydial disease pathogenesis
[5]. The gene expression of a number of pro-inflammatory mediators (IL17A, IL1B, CXCL5,
S100A7 (psoriasin), growth factors (CTGF (connective tissue growth factor)) and matrix metal-
loproteinases (MMP7,MMP9) were up-regulated in TS and TT [1,6–9]. Expression was
increased further when clinical inflammation was present [1,6,7]. Immunohistochemistry
(IHC) studies using tissue from a small number of individuals with active trachoma have
shown that MMP9, CTGF, platelet derived growth factor (PDGF) and IL-1β were up-regulated
in infiltrating monocytes/macrophages and that IL-1β was increased in the conjunctival epithe-
lium [10–12].
Inflammatory mediators, growth factors andMMPs can stimulate epithelial cells to differenti-
ate into pro-fibrotic mesenchymal cells, a process known as epithelial-mesenchymal transition
(EMT) [13–15]. Epithelial cells undergoing EMT lose expression of E-cadherin and gain mesen-
chymal ‘expression’ markers vimentin and α-smooth muscle actin (αSMA) as they migrate
through the basement membrane into the stroma, where they contribute to fibrosis [16]. Inflam-
mation-induced EMT normally ceases when inflammation resolves; therefore EMT only
becomes pathological in an environment of chronic inflammation. The evidence of chronic pro-
inflammatory cytokine and growth factor expression in various stages of trachoma combined
with a fibrotic tissue response suggests that EMTmay contribute to the pathology of trachoma.
The aim of this IHC study of trachomatous conjunctival tissue was to investigate the relative
protein level and tissue localization of pro-inflammatory mediators, growth factors, EMT bio-
markers and MMPs and to characterize the changes in tissue architecture that occur in TT.
Molecular markers studied include factors that were previously shown to be up-regulated in
TS/TT (S100A7, IL-1β, IL-17A, CXCL5, CTGF, MMP7/9), EMT biomarkers (αSMA, vimentin,
E-cadherin) and other factors that may play a role in immunopathology (IL-6 (pleiotropic pro-
inflammatory cytokine), IL-22 (mucosal defense and epithelial integrity), PDGF, transforming
growth factor beta 2 (TGFβ2) (both growth factors associated with fibrosis), and cleaved Cas-
pase 1 (CC1), a marker of inflammasome activation).
Methods
Ethical permission
This study adhered to the tenets of the Declaration of Helsinki and was approved by the Lon-
don School of Hygiene and Tropical Medicine Ethics Committee, the Tanzanian National
Institute of Medical Research Ethics Committee and the Kilimanjaro Christian Medical Centre
Ethics Committee. Written, informed consent was obtained from individuals before enroll-
ment in the study.
Clinical assessment and biopsy sampling
Study participants were examined using a bright torch and x2.5 loupes. The clinical phenotype
of individuals for follicles, papillary inflammation and trichiasis was graded using the World
Health Organization 1981 FPC trachoma grading system [17]. Conjunctival scarring was
graded in finer detail using the system described by Hu et al [18]. Biopsy samples were col-
lected from individuals undergoing bilamellar tarsal rotation surgery for TT (cases) and from
individuals without clinical evidence of trachoma undergoing cataract surgery (controls),
matched by age and sex where possible. The eyelid was anaesthetized with an injection of 2%
lignocaine (Vital Healthcare, Mumbai, India) and the eye was cleaned with 5% povidone
iodine. Biopsy samples were taken from the upper tarsal conjunctiva using a 3mm trephine:
2mm from the lid margin at the junction of the medial⅔ and lateral⅓ of the everted lid. Sam-
ples were fixed in 10% neutral buffered formalin and subsequently embedded in paraffin wax.
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Staining
Formalin-fixed paraffin-embedded (FFPE) samples were cut perpendicular to the conjunctival
surface in 4μm thick sections. Sections were stained with hematoxylin and eosin (H&E) for
examination of tissue health and composition. Sections for IHC staining were dewaxed and
stained with antibodies for pro-inflammatory cytokines and chemokines (IL-6, IL-1β, IL-17A,
IL-22, CXCL5), antimicrobial peptide psoriasin (S100A7), cleaved caspase 1 (CC1), growth fac-
tors (PDGF, CTGF, TGFβ2), matrix metalloproteinases (MMP7, MMP9) and biomarkers of
EMT (E-cadherin, vimentin, αSMA). Antibodies and retrieval methods used are listed in S1
Table. IHC staining was automated and performed using Novocastra Bond Polymer Refine
Red Detection reagents on a Leica BOND instrument (Leica Biosystems, Milton Keynes, UK).
Sections were covered with a cover-slip for microscopic examination.
H&E grading protocol
Tissue sections were graded by an ophthalmic pathologist masked to the clinical status of the
samples. Where more than one H&E section was available for a sample the slide with the most
tissue was analyzed. H&E slides were graded on a scale of 0 to 3 for the degree of epithelial atro-
phy (where 0 is none and 3 is severe atrophy), the number of inflammatory cells present and
the number of myofibroblasts present (0 = no visible staining, 1 = few cells, 2 = moderate num-
ber of cells and 3 = abundant cells). H&E sections were viewed under cross-polarized light in
order to view collagen fiber deposition and grade fibrosis. Fibrotic scarring was graded for 3
patterns, ‘block’, ‘wavy’ and ‘fine’, each on a scale of 0 to 3: 0 = none seen, 1 = focal patches,
2 = abundant areas and 3 = extensive.
IHC grading protocol
Antibodies were graded according to strength and location of staining. For each antibody the sec-
tion was graded separately for the epithelial and the subepithelial compartments. The subepithe-
lial compartment (substantia propria) contained the stroma and inflammatory cell infiltrate if
present. Antibody staining was recorded on a scale of: 0 = no visible staining, 1 = few cells,
2 = moderate number of cells and 3 = abundant cells. For the antibodies targeting E-Cadherin,
vimentin and αSMA staining was recorded in the epithelial compartment only. For E-cadherin,
the total area of the epithelium that stained positive was recorded in quartiles: 0–25% = 1, 26–
50% = 2, 51–75% = 3 and 76–100% = 4.
Data analysis
Data were analysed in R (https://www.r-project.org). Fishers Exact Tests were used to test for
differences between case-control status and: age (categorized by decade), sex, ethnic group,
H&E and IHC scores. IHC targets were excluded from the analysis where2/36 sections had a
grade>0. An unadjusted P value of<0.05 was considered statistically significant for hypothe-
sis-generating purposes. Radial plots were generated by calculating the average score per per-
son for TT cases and controls for each antibody or H&E feature.
Results
Sample phenotypes
Thirty-six conjunctival biopsy specimens were collected from 20 individuals with TT (cases)
and 16 individuals with no clinical signs of trachoma (controls). The demographic and clinical
phenotypes of individuals whose samples were used in this study are described in Table 1.
There was no significant difference in sex (P = 0.31) or age (P = 0.074) between cases and
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controls. There was a significant difference in ethnic groups between cases and controls
(p<0.0001); 18/20 cases were of the Massai ethnic group whereas only one control subject was
Massai. No follicles were detected in cases or controls. One TT case had a papillary inflamma-
tion grade of 3, equivalent to trachomatous inflammation–intense using the simplified grading
system [19]. All cases had varied degrees of conjunctival scarring. None of the controls had
papillary inflammation, scarring or trichiasis (Table 1).
Tissue morphology
H& E staining was used to visualize tissue structure and prevalence of inflammatory cells in sec-
tions. There was no difference in the degree of epithelial atrophy or in the number of myofibro-
blasts between cases and controls (Table 2). There were significantly more inflammatory cells
evident in cases (P = 0.001). Three patterns of subepithelial tissue deposition became apparent
when sections were viewed under cross-polarized light: “block”, “wavy” and “fine”. Representative
photographs of these phenotypes are shown in S1 Fig. Tissue from cases had significantly more
wavy (P = 0.0075) and fine patterns (P = 0.0005) of subepithelial tissue deposition, whereas indi-
viduals with healthy conjunctiva had more block type patterns (P = 0.0005), Table 2 and Fig 1.
Distribution and localization of molecular markers in conjunctival tissue
The relative expression of the different molecular markers detected by IHC in the epithelial
and subepithelial compartments were analysed by case-control status and the results are shown
Table 1. Demographic and clinical characteristics of samples.
Variable Cases Controls
N = 20 N = 16
Gender, male (%) 7 (35%) 9 (56%)
Age, mean in years (range) 74.6 (41–91) 70.3 (50–83)
Ethnic group
Massai 18 1
Chagga 2 7
Other 0 8
Scarring grade
0 0 16
S1b 4 0
S1c 8 0
S2 3 0
3 5 0
Papillary Inﬂammation grade
0 9 16
1 8 0
2 2 0
3 1 0
Trichiasis Grade
0 2 16
1 1 0
2 9 0
3 8 0
2 TT cases that scored 0 for trichiasis grade had marked entropion and had epilated lashes.
doi:10.1371/journal.pntd.0004752.t001
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in Table 3. The average IHC score per person for TT cases and controls for each molecular
marker is also represented in Fig 1. Staining was generally highest in the epithelium of TT
cases. CTGF, IL-1β and CC1 had greater average expression in TT cases in both epithelial and
subepithelial compartments.
CTGF expression was greater in the epithelium of TT cases relative to controls (P = 0.0085).
Of the samples that scored>0 for CTGF, 10/23 had a clinical papillary inflammation grade
>0. Epithelial expression of CTGF was localized in 14/24 of the samples that stained positive.
In 4/24 CTGF positive samples (two cases, two controls) expression was more concentrated in
the deep epithelium (Fig 2A). CTGF expression was slightly greater in the subepithelial tissue
of cases but the difference was not significant.
Significantly more expression of IL-1β was detected in the subepithelial tissue of TT cases
relative to controls (P = 0.012). IL-1β expression was localized around the inflammatory cell
Table 2. Sample characteristics by Hematoxylin and Eosin staining.
Cases Controls P value*
Epithelial Atrophy 0.65
0 6 7
1 7 3
2 5 4
3 1 0
NA† 1 2
Inﬂammatory cell inﬁltrate 0.0025
0 0 1
1 7 13
2 12 1
3 1 1
Myoﬁbroblasts 1
0 2 2
1 8 7
2 8 6
NA† 2 1
Fibrosis: Block pattern 0.0005
0 5 0
1 11 1
2 3 4
3 1 11
Fibrosis: Wavy pattern 0.0075
0 6 13
1 10 3
2 4 0
Fibrosis: Fine pattern 0.0005
0 0 9
1 15 6
2 5 1
* Fishers exact test was used to test for differences between groups. Unadjusted P values are shown.
† Sections received “NA” when there was not enough tissue present to grade a parameter and were not
included in the signiﬁcance calculation.
doi:10.1371/journal.pntd.0004752.t002
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Fig 1. Radial plots summarizing overall changes in tissuemorphology and expression of molecular
markers.Molecular marker expression was quantified by IHC in the epithelial and subepithelial
compartments. The average score per person for TT cases (blue) and controls (red) was plotted for each
target or H&E feature.
doi:10.1371/journal.pntd.0004752.g001
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Table 3. Expression of specific molecular markers in the epithelial and subepithelial compartments by IHC.
Epithelial Compartment Subepithelial Compartment
Category Target Cases (N = 20) Controls (N = 16) P* Cases (N = 20) Controls (N = 16) P*
Pro-inﬂammatory mediators IL-1β 0.312 0.012
0 9 9 11 14
1 1 3 1 2
2 8 4 7 0
3 2 0 1 0
IL-17A 1 NA
0 17 14 20 16
1 2 1 0 0
2 1 1 0 0
3 0 0 0 0
CXCL5 0.241 NA
0 14 14 20 16
1 4 0 0 0
2 2 2 0 0
3 0 0 0 0
S100A7 0.009 NA
0 11 16 20 16
1 5 0 0 0
2 1 0 0 0
3 3 0 0 0
IL-22 0.280 0.806
0 9 11 16 14
1 9 3 1 1
2 2 2 3 1
3 0 0 0 0
IL-6 NA NA
0 19 15 20 16
1 1 1 0 0
2 0 0 0 0
3 0 0 0 0
Inﬂammasome CC1 0.213 0.197
0 9 12 11 14
1 4 3 5 1
2 4 1 2 1
3 3 0 2 0
Growth Factors PDGF 0.689 0.541
0 12 7 15 12
1 4 4 3 3
2 4 4 2 0
3 0 1 0 1
TGFβ2 0.359 0.037
0 13 7 19 12
1 1 4 0 4
2 4 4 0 0
3 2 1 1 0
CTGF 0.008 0.099
(Continued)
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infiltrate (Fig 2C), however, only 5/11 of samples that stained>0 for IL-1β had a clinical papil-
lary grade>0. Expression of IL-1β tended to be higher in the epithelium of TT cases but the
difference was not statistically significant.
S100A7 expression was significantly higher in the epithelium of TT cases (P = 0.0095).
Expression of S100A7 within the epithelium was patchy and in 2 samples expression was local-
ized to pseudoglands of Henle (Fig 2E). All controls stained negative for S100A7. Six of the
nine samples that scored>0 for S100A7 had a clinical papillary grade>0. S100A7 was not
detected in the subepithelial tissue in any sample.
TGFβ2 expression was slightly greater in the subepithelial tissue of controls (P = 0.037).
Four controls were weakly positive (Fig 2H) and one case (papillary grade 3) had stronger
Table 3. (Continued)
Epithelial Compartment Subepithelial Compartment
Category Target Cases (N = 20) Controls (N = 16) P* Cases (N = 20) Controls (N = 16) P*
0 2 10 5 7
1 6 2 8 5
2 11 3 2 4
3 1 1 5 0
Matrix MMP9 0.263 0.556
0 11 8 15 10
1 3 0 2 1
2 6 7 3 5
3 0 1 0 0
MMP7 NA NA
0 18 16 20 14
1 2 0 0 2
2 0 0 0 0
3 0 0 0 0
EMT E-Cadherin 0.314
0 1 0
1 0 3
2 2 2
3 3 1
4 14 10
Vimentin 0.180
0 0 3
1 7 5
2 8 7
3 5 1
αSMA 1
0 12 11
1 1 0
2 5 4
3 2 1
* Fishers exact test was used to test for differences between groups. Unadjusted P values are shown. To account for the burden of repeated statistical
tests applied, critical p-value thresholds of (0.05/13) <0.004 for the epithelial compartment and (0.05/7) <0.007 in the subepithelial compartment would be
required.
doi:10.1371/journal.pntd.0004752.t003
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expression of TGFβ2 in the subepithelial tissue. For the remaining 31 samples TGFβ2 was not
detected in the subepithelial tissue. Epithelial expression of TGFβ2 was not different between
cases and controls.
There were no statistical differences in the expression of EMT biomarkers E-cadherin,
vimentin and αSMA in the epithelium between cases and controls. There were also no statisti-
cal differences between cases and controls in epithelial or subepithelial tissue expression of
CC1, MMP9, PDGF, IL-17A, IL-22 and CXCL5 (Table 3). IL-17A and CXCL5 were not
detected in the subepithelial tissue in any samples. IL-6 and MMP7 were detected in2 of the
36 samples tested.
Fig 2. Example images of IHC staining.CTGF in the deep epithelium of TT cases (A) and controls (B), IL-
1β in TT cases (C) and controls (D), S100A7 in a pseudogland of Henle of a TT case (E) and S100A7 staining
in controls (F) and TGFβ2 staining in TT cases (G) and in controls (H). Images were taken at 200x original
magnification.
doi:10.1371/journal.pntd.0004752.g002
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Discussion
In this study we found that conjunctival tissue of TT cases had significantly greater S100A7
and CTGF expression in the epithelium and significantly greater IL-1β expression in the sube-
pithelial tissue. The average expression of CTGF, IL-1β and CC1 was greater in TT cases in
both epithelial and subepithelial compartments. Controls tended to have more expression of
TGFβ2 in the subepithelial tissue. We did not detect an increase in the expression of EMT bio-
markers in the epithelium of samples from individuals with TT. We found that individuals
with TT had different patterns of collagen deposition and an increased inflammatory cell infil-
trate in the subepithelial compartment relative to individuals without clinical evidence of
trachoma.
In this study the age distribution of cases and controls was comparable. There were more
females among the TT cases, however, this was not a statistically significant. There were sub-
stantially more Maasai people among the cases. This probably reflects greater environmental
and behavioral risk factors [20,21]. Maasai people live in close contact with their livestock (flies
are often abundant) and in areas with fairly limited access to water. Furthermore the uptake of
antibiotics for trachoma control may be lower in these communities [22]. Although genetic
risk factors in Maasai people cannot be excluded, the behavioral and environmental risk factors
leading to increased exposure to C. trachomatis infection probably account for the higher pro-
portion of Maasai among TT cases.
Changes in tissue morphology were clearly evident with a transition from a “block” type
pattern of collagen deposition in controls to “wavy” and “fine” type patterns in cases. This
probably reflects the progressive disruption of normal connective tissue. Degradation of orga-
nized bundles of collagen fibers running parallel with the epithelium (“block” type) by MMPs
or oedema could create the fragmented “wavy” and “fine” patterns observed. A similar observa-
tion has previously been shown in the subepithelial tissue of individuals with scarring trachoma
and was found to correlate with tissue scarring determined by in vivo confocal microscopy
(IVCM) [23]. There is an apparent mismatch in the features of TS when tissue is observed by
the 2 different methods; using IVCM, defined bands of scarring were observed, whereas by his-
tology collagen bundles appear fragmented and amorphous. It is possible that the bands of
scarring (observed by IVCM in 3 dimensions) disrupt the parallel collagen bundles (seen on a
section in 2 dimensions) to produce wavy and fine patterns of collagen in cases. It was not pos-
sible to grade fibrosis in subepithelial tissue with the same grading system described in Hu et al
[23] as tissue sections were not sufficient in size. The baseline “T” collagen structure indicative
of healthy tissue in controls was visible only in one control section.
More inflammatory cells were identified in tissue from TT cases. This result is in keeping
with the range of clinical inflammatory grades observed in cases, whereas all controls had a
clinical inflammation grade of 0. It is perhaps surprising that epithelial atrophy, thought to be a
common feature of scarring trachoma, and the number of myofibroblasts were not different
between cases and controls. Epithelial atrophy has been reported in two studies that used sam-
ples from 11 and 29 individuals with TT and entropion, however neither study included con-
trols [24,25]. The same two studies also reported epithelial hyperplasia and psuedogland
formation [24,25]. Persistent and recurrent conjunctival inflammation and associated hyper-
plasia are thought to promote the formation of pseudoglands of Henle, which are crypts
formed by invagination of the epithelium [26]. Bacteria and debris can become trapped by
mucus within these crypts and entrapped secretions within pseudoglands were observed in
individuals with TT [24,26]. Myofibroblasts have contractile properties therefore one might
speculate that they have an increased role during TS and TT. In line with our observations we
did not detect any significant differences in the epithelial expression of the EMT biomarkers
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vimentin, αSMA or E-cadherin between cases and controls, although vimentin expression was
slightly increased in TT cases. The number of samples in this study was relatively small and
there was only one sample from an individual with trachomatous inflammation–intense, there-
fore it is possible we did not have sufficient power within the study to detect subtle, transient or
rare events. We only graded loss of E-cadherin and gain of vimentin and αSMA expression in
the epithelium, as it would not be possible to distinguish cells expressing vimentin and αSMA
in the subepithelial tissue from normal fibroblasts/myofibroblasts. Future work such as multi-
plex staining or application of new techniques such as laser ablation mass cytometry are
required to distinguish complex cell phenotypes and rare events such as cells undergoing EMT
[27].
IHC staining was generally greater in the epithelial compartment relative to the subepithe-
lial compartment. CC1, CTGF and IL-1β were increased in both epithelial and subepithelial
compartments in TT cases (Fig 1) and S100A7 was increased in the epithelium. CC1 cleaves
IL-1β into its active form and the concomitant upregulation of CC1 and IL-1β reflects activa-
tion of the inflammasome [28]. In the subepithelial tissue of TT cases IL-1β was localized
around the inflammatory cell infiltrate. Just over half of the samples that stained positive for
IL-1β in the subepithelial tissue had no evidence of clinical inflammation; therefore consider-
able levels of IL-1β were expressed in the absence of clinical signs. Recent evidence showed that
IL-1β expression was weakly associated with progressive scarring trachoma and strongly asso-
ciated with inflammatory episodes [1]. It is possible that IL-1β remains up-regulated in the sub-
epithelial tissue in individuals without evidence of clinical inflammation, as this study might
suggest, but that cytokines expressed in the subepithelial tissue are less readily detected when
samples are collected using a superficial conjunctival swab. Chronic IL-1 induced inflamma-
tion is known to result in tissue remodeling [29,30].
CTGF modulates the interaction of cells with the extracellular matrix; promoting collagen
deposition, mesenchymal cell activation and differentiation (including EMT) and tissue
remodeling [14,31]. CTGF was previously shown by IHC to be upregulated in infiltrating
monocytes/macrophages of children with active trachoma [12], however we demonstrate an
upregulation of CTGF in both the subepithelium and epithelium of TT cases. This difference
could reflect the different clinical stages of trachoma in the samples studied. TGFβ induces
CTGF expression in fibroblasts and epithelial cells therefore it is surprising that we did not see
a concomitant up-regulation of TGFβ in TT cases alongside CTGF [32–34]. A number of bac-
teria have been shown to stimulate CTGF expression in epithelial cells via the lysophosphatidic
acid receptor [35], therefore it is possible that CTGF is directly induced in the epithelium by
the altered ocular microbiota observed in individuals with trachoma [18,36]. Over-expression
of CTGF drives fibrosis in a number of diseases [32,37,38] and it has become apparent that epi-
thelial-derived CTGF can drive fibrosis in the underlying subepithelial tissue [34,39]. CTGF
was detected in the basal epithelium in four samples (Fig 2A). CTGF staining in the basal epi-
thelium has previously been reported in the context of gingival fibrosis, where it was thought to
have a role in cell proliferation and epithelial hyperplasia [40]. This could drive the formation
of pseudoglands in addition to driving fibrosis in the underlying tissue. CTGF was strongly
associated with clinical inflammation in adults with progressive scarring trachoma [1], how-
ever in the present study CTGF did not appear to be preferentially detected in adults with evi-
dence of clinical inflammation.
S100A7 is a pro-inflammatory antimicrobial peptide secreted by epithelial cells. S100A7 was
only detected in the epithelium of TT cases in this study and expression was generally patchy,
possibly suggesting a localized antimicrobial response. In addition to direct antibacterial action,
S100A7 recruits CD4+ T cells and neutrophils and amplifies pro-inflammatory cytokine
responses [41–43]. In two samples staining was detected around pseudoglands of Henle,
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possibly reflecting a local inflammatory response to bacteria that had accumulated within the
pseudogland. Positive staining of the epithelium around these pseudoglands was also noted for
IL-1β in 4 TT cases. No positive staining was detected around pseudoglands in control tissue
for any of the antibodies tested. Due to the small size of the tissue sections it was not possible to
compare the number of pseudoglands between cases and controls. Further study is required to
identify whether trachomatous inflammation promotes pseudogland formation and whether
bacteria trapped within pseudoglands have a role in exacerbating inflammation.
Latent TGFβ2, PDGF and MMP9 expression tended to be slightly higher in controls.
TGFβ2 expression in controls was relatively weak and non-specific therefore could be attrib-
uted to a high background. The antibody used detected the latent form of TGFβ2, therefore it
is possible that more latent TGFβ2 was present in controls whereas cases had activated and
released TGFβ2. Despite having a well-defined role in tissue fibrosis, no previous associations
have been found between TGFβ2 and trachoma at both expression and protein levels (Holland,
Mabey and Bailey; personal communication) [44]. Full characterization of the role of TGFβ2 in
trachoma has been limited due to its complex post-translational modifications.
IL-17A, CXCL5, PDGF, MMP7 and MMP9 have previously been associated with various
stages of trachoma (trachomatous inflammation–follicular [10,11,44,45], TS [1,6,7] and TT
[8,9]) at mRNA and protein expression levels, however they were not demonstrably up-regu-
lated in TT cases in the present study. MMP7, CXCL5 and IL-17A were strongly associated
with inflammatory episodes but not with progressive scarring in two large cohorts of individu-
als with trachoma [1]. The failure to detect differences in staining in this study could be due to
the lack of clinical inflammation in the individuals from whom samples were obtained, or due
to a lack of study power to detect more subtle differences. It could also be biological and might
suggest that differences at the expression level are not maintained at the protein level. The fail-
ure to detect MMP7 and IL-6 could likewise be due to a lack of clinical inflammation, a lack of
expression or due to the sensitivity of the antibodies used. IL-22 is released alongside IL-17 by
Th17 cells and contributes to mucosal defense and maintenance of epithelial integrity but also
to the pathogenesis of psoriasis [46,47]. Although IL-22 has not previously been associated
with trachoma we hypothesized it might have a role in conjunctival epithelial inflammation or
health [48], however no differences in expression were detected.
We did not to collect swabs for C. trachomatis PCR because the swabbing process would
have probably altered the surface tissue appearance. However, from contemporary studies it is
known that the prevalence of C. trachomatis infection in this region among individuals with
trachomatous scarring is very low, and therefore it is likely that few if any of these case would
have been infected [1]. Similarly, it was not possible to collect conjunctival swab samples for
mRNA gene expression analysis from these individuals as this would have affected the histo-
logical analysis. Our previous gene expression work used mRNA collected from surface swabs.
Therefore, we would not necessarily expect these to exactly correspond to this immunohis-
tochemistry study, which is assessing protein mostly in deeper levels.
We have demonstrated that individuals with TT had significantly increased levels of CTGF
and S100A7 in the epithelium and IL-1β in the subepithelial tissue, even in the absence of
marked clinical inflammation. CTGF, IL-1β and CC1 were increased in TT cases in both epi-
thelial and subepithelial compartments. We suggest that microbial stimulation of the epithe-
lium, ongoing sub-clinical inflammation and inflammasome activation in the connective tissue
and CTGF-driven fibrosis contribute to the pathology of trachoma. We also described a poten-
tial role for pseudoglands of Henle in trachoma that warrants further investigation. These
results and hypothesized mechanisms are summarized in a model figure (Fig 3). CTGF could
be responsible for driving inflammation-induced fibrosis in trachoma, making it a potential
therapeutic target [49]. Future research should focus on the stimuli that lead to up-regulation
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of CTGF, S100A7 and IL-1β and potential inhibitors that could halt the progression of
scarring.
Fig 3. Model figure summarizing molecular marker expression, inflammatory cell infiltration and tissue morphology changes
observed in trichiasis tissue, including hypothesizedmechanisms driving scarring. “L” = lymphocytes.
doi:10.1371/journal.pntd.0004752.g003
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